D-002. Antiulcer, antioxidant, antiinflammatory

Drugs of the Future

Volumn 26, Issue 8, 2001, Pages 731-744

  Mas R ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ABEXOL; ALKANOL; BEESWAX ALCOHOL; D 002; DOTRIACONTANOL; HEXACOSANOL; OCTACOSANOL; TETRACOSANOL; TETRATRIACONTANOL; TRIACONTANOL; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BEE EXTRACT; CHEMICAL COMPOSITION; DRUG ISOLATION; DRUG METABOLISM; EXPERIMENTAL ANIMAL; HONEYBEE; HUMAN; MUTAGENICITY; NONHUMAN; PEPTIC ULCER; QUALITY CONTROL; REPRODUCTIVE TOXICITY; REVIEW;

EID: 0034782055     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2001.026.08.630956     Document Type: Review

References (102)

1. Pathogenesis of peptic ulcer disease and gastritis: Importance of aggressive and cytoprotective factors
2. Augmentation of the gastric mucosal defense mechanism induced by KW-5805, a novel antiulcer agent
3. Proton pump inhibition for acid-related disease
4. Long-term treatment for gastric and duodenal ulcer
5. Rates of duodenal ulcer healing by drug classes: A meta-analysis
6. Role of mucus in gastric mucosal protection
7. Gastroduodenal mucus and bicarbonate. The defensive zone
8. Removing oxygen-derived free radicals stimulated healing of ethanol-induced erosive gastritis in the rat
9. The significance of removing oxygen-derived free radicals in the treatment of acute and chronic duodenal ulceration in the rat
10. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis
11. Omeprazole: An update of its pharmacology and therapeutic use in acid-related disorders
12. Lansoprazole: A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders
13. Long-term treatment of patients with gastric ulcer: Sucralfate versus ranitidine versus no treatment: An interim report at the end of year 1 of a 3-year multicenter, randomized study
14. Angioedema and urticaria associated with omeprazole
15. Endocrine adverse effects of omeprazole
16. Hemolytic anemia associated with the use of omeprazole
17. Beeswax - Composition and analysis
18. Anti-ulcer activity of higher primary alcohols of beeswax
19. Possible cytoprotective mechanism in rats of D-002 an anti-ulcerogenic product isolated from beeswax
20. Effects of D-002 on gastric mucus composition in ethanol induced ulcer
21. Comparative study of the antiulcer effects of D-002 with sucralfate and omeprazole
22. Anti-inflammatory activity of D-002: An active product isolated from beeswax
23. Pharmacological approach to tissue injury mediated by free radicals and other reactive oxygen metabolites
24. Role of oxygen-derived radicals in the pathogenesis of gastric mucosal lesions in rats
25. Free radicals and lipid peroxidation in ethanol or aspirin induced gastric mucosal injury
26. Role of oxygen derived free radicals in indomethacin induced gastric injury
27. Free radicals and antioxidant status following pylorus ligation induced gastric mucosal injury in rats
28. Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats
29. Role of oxygen-derived radicals in the pathogenesis of gastric mucosal lesions in rats
30. Inhibition of rat microsomal lipid peroxidation by the oral administration of D-002
31. Mechanism of carbon tetrachloride toxicity
32. Effects of toluene and its metabolites on cerebral reactive oxygen species
33. Central nervous system trauma and stroke. Biochemical consideration for oxygen radicals formation and lipid peroxidation
34. Studies on lipid peroxidation in the rat brain
35. Superoxide dismutases
36. Superoxide dismutase activity, oxidative damage, and mitocondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis
37. Glutatione peroxidase brought into focus
38. Antioxidant effects of D-002 on gastric mucosa of rats with injury induced experimentally
39. Role of oxygen-derived free radicals in gastric mucosal injury induced by ischemia reperfusion in rats
40. Protective effect of cystathionine on acute gastric mucosal injury induced by ischemia-reperfusion in rats
41. Role of lipid peroxidation and antioxidants in gastric mucosal injury induced by the hipoxanthine-xantine oxidase system in rats
42. A new gastric ulcer model induced by ischemic-reperfusion in the rat: Role of leukocytes on ulceration in rat stomach
43. Polymorphonuclear leukocyte-mediated cell and tissue injury: Oxygen metabolites and their relation to human diseases
44. The pathogenesis of NSAID-gastrophaty-are neutrophils the culprits-?
45. Protective effect of iloprost and UK 38 485 against gastric mucosal damage induced by various stimuli
46. Pentoxyfylline-associated reduction of indomethacin-induced rat gastric mucosal injury is supported by decreased lipid peroxidation
47. Indomethacin-induced leukocyte adhesion in mesenteric venules: Role of lipoxygenase products
48. Enhanced gastric mucosal leukotriene B4 synthesis in patients taking nonsteroidal anti-inflammatory drugs
49. Molecular determinants of aspirin induced neutrophil adherence to endothelial cells
50. Effect of D-002 on the preulcerative phase of carragenin-induced colonic ulceration in the guinea pig
51. Effect of D-002 on acetic acid-induced colitis in rats at single and repeated doses
52. A comparative study of D-002 vs sulfasalazine on acetic acid-induced colitis in rats
53. Policosanol
54. Policosanol inhibits cholesterol biosynthesis and enhances LDL processing in cultured human fibroblasts
55. Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolemia induced by a wheat starch-casein diet
56. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors
57. Effect of policosanol on post-menopausal women with type II hypercholesterolemia
58. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients
59. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus
60. A comparison of the pharmacological profile of D-002 and policosanol, two different mixtures of high molecular weight alcohols
61. Effects of policosanol on platelet aggregation in rats
62. Pharmacological study of the interaction between policosanol and aspirin in experimental animals
63. Effect of policosanol on platelet function in healthy volunteers
64. Effect of policosanol successive dose increases on platelet aggregation in healthy volunteers
65. Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers
66. Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro
67. Effects of policosanol on the low density lipoprotein (LDL) isolated on hypercholesterolemic patients at high coronary risk to in vitro copper mediated lipid peroxidation
68. Effect of policosanol on in vitro and in vivo rat liver microsomal lipid peroxidation
69. Oral administration of policosanol inhibits in vitro copper ion-induced rat lipoprotein peroxidation
70. 2 assimilation
71. Stimulation of ATPase in barkley (Hordeum vulgare) root plasma membrane after treatment of intact tissues and cell free extracts with triacontanol
72. Evaluation of triacontanol-containing compounds as anti-inflammatory agents using guinea-pig models
73. Neurotrophic effect of naturally occurring long-chain fatty alcohols on cultured CNS neurons
74. Peripheral administration of a long-chain fatty alcohol promotes septal cholinergic neurons survival after fimbria-fornix transection
75. The neurotrophic factor, n-hexacosanol, reduces the neuronal damage induce by the neurotoxin, kainic acid
76. Studies on the immunological effects of fatty alcohols I. Effects of n-hexacosanol on murine macrophage in culture
77. Enhancement of mouse sciatic nerve regeneration by the long chain fatty alcohol n-hexacosanol
78. A 12 months study of policosanol oral toxicity in Sprague-Dawley rats
79. Toxicity of policosanol in Beagle dogs: One year study
80. Multigeneration reproduction study of policosanol in rats
81. Carcinogenicity of policosanol in Sprague Dawley rats: A 24 months study
82. Pharmacoepidemiologic study of policosanol
83. Policosanol: Results of a postmarketing surveillance control on 27,879 cases
84. Acute oral toxicology of D-002 in Sprague Dawley rats
85. Preclinical oral toxicology in rats of D-002 a natural drug with antiulcer effects
86. Oral toxicological studies of D-002 in mice
87. A one year study of D-002. A mixture of aliphatic primary alcohols in Beagle dogs
88. Mutagenic evaluation of D-002 in the micronucleus test in bone marrow in Sprague Dawley rats of both sexes
89. Genotoxic study of D-002, a product with antiulcer activity
90. Developmental toxicity of D-002 a mixture of aliphatic primary alcohols in rats and rabbits
91. Effects of D-002, a product isolated from beeswax on duodenal ulcer: A double-blinded placebo-controlled study
92. Gastroprotective effect of D-002 in patients with osteoarthritis treated with piroxicam: A pilot study
93. Free radicals, antioxidant and aging
94. Role of free radicals in aging and disease
95. Antioxidant status in persons with and without senile cataracts